Main menu:
Update: 2019/07/30
Project in progress |
||
Name |
Project |
|
Aytaj Baratova |
||
Elisabeth Blüthner |
Modification of liver function and liver structure caused by parenteral nutrition |
elisabeth.bluethner@charite.de |
Friedrich Dettmann |
Quality of Life and Cost Study in chronic liver failure |
friedrich.dettmann@charite.de |
Max Stärk |
Quality of Life and Cost Study in chronic liver failure |
max.staerk@charite.de |
Folke Richter |
Influence of manifest cirrhosis on postoperative morbidity |
folke.richter@charite.de |
Julia Rjasanow |
Milzvolumen als diagnostischer Parameter bei Leberzirrhose und der Morbidität durch portale Hypertension |
julia.rjasanow@charite.de |
Antonia Rothkäppel |
Long- |
antonia.rothkaeppel@charite.de |
Ritesh Shrestha |
Influence of manifest cirrhosis on postoperative morbidity |
aaaritesh@gmail.com |
Julia Rjasanow |
Milzvolumen als diagnostischer Parameter bei Leberzirrhose und der Morbidität durch portale Hypertension |
julia.rjasanow@charite.de |
Lina Demirel |
Clinical course of patients with Klatskin- |
lina.demirel@charite.de |
Amir Kotobi |
Influence of acute cholestasis on the liver function |
amir- |
Katja Lüttgert |
Prognostic potential of different tests for liver function and liver morphology in patients with liver cirrhosis |
katja.luettgert@charite.de |
Project closed |
||
Annekathrin Baron |
Prediction of partial liver function and volume after portal vein embolisation |
|
Navid Ahmadi |
Early diagnosis of liver failure in septic patients using the LiMAx test |
|
Juliane Aurich |
Expression patterns of cytokines and growth factors after liver resection and their influence on liver regeneration |
|
Jan Bednarsch |
Influence of Oxaliplatin based FOLFOX and CAPOX- |
|
Konstantin Bias |
Quality of Life and Cost Study in chronic liver failure |
|
Susanne Biele |
Prognostic potential of different tests for liver function and liver morphology in patients with liver cirrhosis |
|
Tim Brötzmann |
Evaluation of a tablet- |
|
Franziska Herrmann |
Expression patterns of cytokines and growth factors after liver resection and their influence on liver regeneration |
|
Steffi Hoppe |
Transcriptional pathways of hepatic steatosis |
|
Thomas Keuchel |
Prediction of partial liver function and volume after portal vein embolisation |
|
Antje Kirchstein |
Virtual preoperative planning of the residual liver volume and function in patients undergoing oncological liver resection |
|
Erika Valle |
Liver function adapted tacrolimus- |
|
Tim Reese |
Expression patterns of cytokines and growth factors after liver resection and their influence on liver regeneration |
|
Julia Rjasanow |
Spleen size as a risk factor for cirrhosis and cirrhosis- |
|
Stephanie Rolle |
Quality of Life of liver transplant candidates |
|
Darius Ferenc Rüther |
Evaluation of a tablet- |
|
Alfonso Scharfenberg |
Valid non invasive diagnosis of liver cirrhosis using the LiMAx test |
|
Pouria Taheri |
Formation distribution and clearance of 13CO2 to improve the quality of 13C- |
|
Hannah Vetter |
Early diagnosis of liver failure in septic patients using the LiMAx test |
|
Nikolay Videv |
Changes in growth hormon and glucose metabolism after liver resection |
|
Clemens Wagner |
Prediction of partial liver function and volume after portal vein embolisation |
|
Constantin Weber |
||
Teresa Weber |
Influence of radiotherapy on liver capacityfor the treatment of liver cancer |
|
Benjamin Weigang |
Insulin resistance in the post operative course after liver surgery |
|
Tilmann Westphal |
Influence of chemotherapy on liver capacity |
|
Felix Wohlgemuth |
Expression patterns of cytokines and growth factors after liver resection and their influence on liver regeneration |
|